Traitement du gliome infiltrant du tronc cérébral par un régulateur épigénétique : rôle d’EBP50 et d'IRSp53

Abstract : Diffuse Intrinsic Pontine Glioma (DIPG), is a rare and highly aggressive pediatric tumor. The average survival time after diagnosis is less than one year. A major genetic characteristic of this disease is the mutation of histone H3 (H3K27M). The evolution of knowledge in epigenetics has made it possible to design epigenetic regulatory inhibitors able to modify, or even offset, the effect of this mutation. For example, panobinostat (PS), a histone deacetylase inhibitor, reduces cell growth and induces DIPG cell death, both in vitro and in vivo. Its effectiveness is currently being evaluated in clinical trials. My thesis project aimed at determining the role of two proteins, EBP50 and IRSp53, deregulated in different DIPG cell lines after treatment with PS. EBP50 has already been described as involved in tumor progression but its dual function, both oncogenic and tumor suppressor, has led us to further investigate its role in the DIPG cells. IRSp53 has been poorly studied in solid cancers, though it plays an important role in cell motility and invasion. Down-regulation by RNA silencing of these two proteins in DIPG cell lines induces apoptosis, decreases cell growth and motility, leading us to the hypothesis that these two proteins are oncogenic proteins. In addition, the cytoplasmic and nuclear localization of the EBP50 protein is consistent with its oncogenic role in DIPG cells. Then, I investigated the effect of combinatorial therapy that associates PS with EBP50 or IRSp53 expression inhibitors. My results show an increase in the antitumor effect in vitro for both proteins but also in vivo for EBP50, in a preclinical model, the chicken embryo. In conclusion, these two proteins could be the targets of new treatments for DIPG tumors in combination with PS to enhance its efficacy.
Document type :
Theses
Complete list of metadatas

Cited literature [442 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-02179630
Contributor : Abes Star <>
Submitted on : Thursday, July 11, 2019 - 1:02:13 AM
Last modification on : Thursday, July 11, 2019 - 1:05:00 AM

File

CAPDEVIELLE_CAROLINE_2018.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-02179630, version 1

Collections

Citation

Caroline Capdevielle. Traitement du gliome infiltrant du tronc cérébral par un régulateur épigénétique : rôle d’EBP50 et d'IRSp53. Médecine humaine et pathologie. Université de Bordeaux, 2018. Français. ⟨NNT : 2018BORD0405⟩. ⟨tel-02179630⟩

Share

Metrics

Record views

127

Files downloads

85